Amylyx Pharmaceuticals: Avexitide Defines The Endocrine Rebuild (NASDAQ:AMLX)
· seekingalpha.com
Amylyx shifts to endocrine with avexitide in Phase 3 LUCIDITY for post-bariatric hypoglycemia; cash runway to 2028. Click here to read more.
Amylyx Pharmaceuticals ( AMLX ) is still frequently viewed through the lens of RELYVRIO (and ultimately the unsuccessful PHOENIX confirmatory trial) in ALS. How...